{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:39:14Z","timestamp":1792841954815,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173392"],"award-info":[{"award-number":["82173392"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573342"],"award-info":[{"award-number":["82573342"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2026JJ82189"],"award-info":[{"award-number":["2026JJ82189"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024B1515040006"],"award-info":[{"award-number":["2024B1515040006"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.actbio.2026.10.019","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:19:02Z","timestamp":1791904742000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor-triggered DNA fragmentation with a nucleus-targeted nanodrug for precise cGAS-STING activation and enhanced cancer immunotherapy"],"prefix":"10.1016","author":[{"given":"Qian","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shili","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9785-6731","authenticated-orcid":false,"given":"Xiaoding","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2026.10.019_bib0001","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.cell.2015.08.038","article-title":"Releasing the brakes on cancer immunotherapy","volume":"162","author":"Littman","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2026.10.019_bib0002","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.actbio.2026.10.019_bib0003","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41392-023-01522-4","article-title":"Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.actbio.2026.10.019_bib0004","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2026.10.019_bib0005","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41568-021-00343-3","article-title":"Overcoming hurdles in cancer immunotherapy","volume":"21","author":"York","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2026.10.019_bib0006","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","article-title":"The future of cancer immunotherapy: microenvironment-targeting combinations","volume":"30","author":"Murciano-Goroff","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.actbio.2026.10.019_bib0007","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41577-024-01112-7","article-title":"Regulation of cGAS-STING signalling and its diversity of cellular outcomes","volume":"25","author":"Zhang","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.actbio.2026.10.019_bib0008","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.actbio.2026.10.019_bib0009","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.3123","article-title":"Control of adaptive immunity by the innate immune system","volume":"16","author":"Iwasaki","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.actbio.2026.10.019_bib0010","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.tcb.2022.11.001","article-title":"Cellular functions of cGAS-STING signaling","volume":"33","author":"Chen","year":"2023","journal-title":"Trend. Cell Biol."},{"key":"10.1016\/j.actbio.2026.10.019_bib0011","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/s41590-024-01872-3","article-title":"The balance of STING signaling orchestrates immunity in cancer","volume":"25","author":"Lanng","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.actbio.2026.10.019_bib0012","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12943-024-02186-6","article-title":"Nanomedicines harnessing cGAS-STING pathway: sparking immune revitalization to transform \u2018cold\u2019 tumors into \u2018hot\u2019 tumors","volume":"23","author":"Ying","year":"2024","journal-title":"Mol. Cancer."},{"key":"10.1016\/j.actbio.2026.10.019_bib0013","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.mattod.2024.07.004","article-title":"Targeting activation of cGAS-STING signaling pathway by engineered biomaterials for enhancing cancer immunotherapy","volume":"78","author":"Liang","year":"2024","journal-title":"Mater. Today"},{"key":"10.1016\/j.actbio.2026.10.019_bib0014","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1021\/acsnano.4c12237","article-title":"Activating the cGAS-STING pathway by manganese-based nanoparticles combined with platinum-based nanoparticles for enhanced ovarian cancer immunotherapy","volume":"19","author":"Zhang","year":"2025","journal-title":"ACS Nano."},{"key":"10.1016\/j.actbio.2026.10.019_bib0015","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1158\/2159-8290.CD-18-1020","article-title":"Argeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer","volume":"9","author":"Sen","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.actbio.2026.10.019_bib0016","article-title":"Hybrid nanoparticle-mediated simultaneous ROS scavenging and STING activation improve the antitumor immunity of in situ vaccines","volume":"10","author":"Li","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.actbio.2026.10.019_bib0017","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr1728","article-title":"Tumor-targeting nanocarriers amplified immunotherapy of cold tumors by STING activation and inhibiting immune evasion","volume":"11","author":"Zhao","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.actbio.2026.10.019_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121856","article-title":"Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy","volume":"290","author":"Cao","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.10.019_bib0019","article-title":"Cancer radiosensitization nanoagent to activate cGAS-STING pathway for molecular imaging guided synergistic radio\/chemo\/immunotherapy","volume":"13","author":"Wu","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.actbio.2026.10.019_bib0020","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1021\/acsnano.3c09293","article-title":"An immunocompetent hafnium oxide-based STING nanoagonist for cancer radio-immunotherapy","volume":"18","author":"Cao","year":"2024","journal-title":"ACS Nano."},{"key":"10.1016\/j.actbio.2026.10.019_bib0021","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/mco2.103","article-title":"Targeting DNA repair pathway in cancer: mechanisms and clinical application","volume":"2","author":"Wang","year":"2021","journal-title":"MedComm"},{"key":"10.1016\/j.actbio.2026.10.019_bib0022","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","article-title":"DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.actbio.2026.10.019_bib0023","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13073-025-01488-8","article-title":"DNA repair and the contribution to chemotherapy resistance","volume":"17","author":"Nesic","year":"2025","journal-title":"Genom. Med."},{"key":"10.1016\/j.actbio.2026.10.019_bib0024","article-title":"DNase I-mediated chemotactic nanoparticles for NETs targeting and microenvironment remodeling treatment of acute ischemic stroke","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.actbio.2026.10.019_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123095","article-title":"Inhalable DNase I@Au hybrid nanoparticles for radiation sensitization and metastasis inhibition by elimination of neutrophil extracellular traps","volume":"317","author":"Sun","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.10.019_bib0026","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jconrel.2015.04.028","article-title":"Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections","volume":"209","author":"Baelo","year":"2015","journal-title":"J. Control. Releas."},{"key":"10.1016\/j.actbio.2026.10.019_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202404584","article-title":"Development of DNase-1 loaded polymeric nanoparticles synthesized by inverse flash nanoprecipitation for neutrophil-mediated drug delivery to in vitro thrombi","volume":"14","author":"Maiocchi","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.actbio.2026.10.019_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131514","article-title":"Nucleus-targeting DNase I self-assembly delivery system guided by pirarubicin for programmed multi-drugs release and combined anticancer therapy","volume":"267","author":"He","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.actbio.2026.10.019_bib0029","doi-asserted-by":"crossref","first-page":"10342","DOI":"10.1039\/D2SC03861G","article-title":"Nucleus-selective codelivery of proteins and drugs for synergistic antitumor therapy","volume":"13","author":"Yang","year":"2022","journal-title":"Chemi. Sci."},{"key":"10.1016\/j.actbio.2026.10.019_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202101219","article-title":"Nucleus-targeted delivery of multi-protein self-assembly for combined anticancer therapy","volume":"17","author":"Tang","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.actbio.2026.10.019_bib0031","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/cncr.10987","article-title":"Decreased expression of DFF45\/ICAD is correlated with a poor prognosis in patients with esophageal carcinoma","volume":"95","author":"Konishi","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.actbio.2026.10.019_bib0032","first-page":"1179","article-title":"Using apoptosis for targeted cancer therapy by a new gonadotropin releasing hormone-DNA fragmentation factor 40 chimeric protein","volume":"9","author":"Ben-Yehudah","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2026.10.019_bib0033","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12032-024-02511-5","article-title":"DNA fragmentation factor 40-based therapeutic approaches for cancer: a review article","volume":"41","author":"Masaeli","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.actbio.2026.10.019_bib0034","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/34112","article-title":"A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD","volume":"391","author":"Enari","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2026.10.019_bib0035","doi-asserted-by":"crossref","first-page":"8461","DOI":"10.1073\/pnas.95.15.8461","article-title":"The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis, roc","volume":"95","author":"Liu","year":"1998","journal-title":"Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actbio.2026.10.019_bib0036","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nchembio814","article-title":"Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy","volume":"2","author":"Putt","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.actbio.2026.10.019_bib0037","first-page":"738","article-title":"Caspase 3 in breast cancer","volume":"9","author":"O'Donovan","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2026.10.019_bib0038","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41419-024-06884-3","article-title":"Caspase-3 promotes oncogene-induced malignant transformation via EndoG-dependent Src-STAT3 phosphorylation","volume":"15","author":"Zhu","year":"2024","journal-title":"Cell. Death. Dis."},{"key":"10.1016\/j.actbio.2026.10.019_bib0039","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12943-025-02274-1","article-title":"Modulating lipid metabolism by nanoparticles (NPs)-mediated ACSL3 silencing to inhibit hepatocellular carcinoma growth and metastasis","volume":"24","author":"Huang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.actbio.2026.10.019_bib0040","article-title":"Remodeling of mitochondrial metabolism by a mitochondria-targeted RNAi nanoplatform for effective cancer therapy","volume":"20","author":"Xu","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.actbio.2026.10.019_bib0041","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202500646","article-title":"Dual-responsive immunomodulatory RNAi nanoplatform for effective immune checkpoint blockade and enhanced cancer immunotherapy","volume":"14","author":"Cao","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.actbio.2026.10.019_bib0042","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.actbio.2024.12.061","article-title":"Nanoparticle-mediated efficient up-regulation of GSDMD-N to induce pyroptosis and enhance NK cell-based cancer immunotherapy","volume":"193","author":"Huang","year":"2025","journal-title":"Acta. Biomater."},{"key":"10.1016\/j.actbio.2026.10.019_bib0043","article-title":"Nucleus-specific RNAi nanoplatform for targeted regulation of nuclear lncRNA function and effective cancer therapy","volume":"2","author":"Huang","year":"2022","journal-title":"Exploration"},{"key":"10.1016\/j.actbio.2026.10.019_bib0044","article-title":"LCDR regulates the integrity of lysosomal membrane by hnRNP K stabilized LAPTM5 transcript and promotes cell survival","volume":"119","author":"Yang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actbio.2026.10.019_bib0045","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1128\/AAC.00798-13","article-title":"Effect of a high-calorie, high-fat meal on the bioavailability and pharmacokinetics of PA-824 in healthy adult subjects","volume":"57","author":"Winter","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actbio.2026.10.019_bib0046","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1002\/anie.201601273","article-title":"Ultra-pH-responsive and tumor-penetrating nanoplatform for targeted siRNA delivery with robust anti-cancer efficacy","volume":"55","author":"Xu","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.actbio.2026.10.019_bib0047","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1021\/acsnano.6b07195","article-title":"Multifunctional envelope-type siRNA delivery nanoparticle platform for prostate cancer therapy","volume":"11","author":"Xu","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2026.10.019_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123568","article-title":"Chrono-controlled hydrogel platform orchestrates metabolic reprogramming and cuproptosis-driven immune activation against triple-negative breast cancer","volume":"325","author":"Lu","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.10.019_bib0049","article-title":"Remodeling serine synthesis and metabolism via nanoparticles (NPs)-mediated CFL1 silencing to enhance the sensitivity of hepatocellular carcinoma to sorafenib","volume":"10","author":"Li","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.actbio.2026.10.019_bib0050","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.bpj.2010.09.012","article-title":"Characterization of PicoGreen interaction with dsDNA and the origin of its fluorescence enhancement upon binding","volume":"99","author":"Dragan","year":"2010","journal-title":"Biophys. J."},{"key":"10.1016\/j.actbio.2026.10.019_bib0051","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13046-024-02960-w","article-title":"T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution","volume":"43","author":"Yang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.actbio.2026.10.019_bib0052","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adr9131","article-title":"The lncRNA EPIC1 suppresses dsRNA-induced type I IFN signaling and is a therapeutic target to enhance TNBC response to PD-1 inhibition","volume":"18","author":"Pattarayan","year":"2025","journal-title":"Sci. Signal."},{"key":"10.1016\/j.actbio.2026.10.019_bib0053","doi-asserted-by":"crossref","first-page":"13226","DOI":"10.1021\/acsnano.4c02337","article-title":"Triune nanomodulator enables exhausted cytotoxic T lymphocyte rejuvenation for cancer epigenetic immunotherapy","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126006975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126006975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:33:48Z","timestamp":1792841628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706126006975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":53,"alternative-id":["S1742706126006975"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.10.019","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-triggered DNA fragmentation with a nucleus-targeted nanodrug for precise cGAS-STING activation and enhanced cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}